Filing Details

Accession Number:
0001415889-24-003448
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-02-12 19:46:31
Reporting Period:
2024-02-08
Accepted Time:
2024-02-12 19:46:31
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1786205 Arcellx Inc. ACLX Biological Products, (No Disgnostic Substances) (2836) 472855917
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1789632 Christopher Heery C/O Arcellx, Inc.
800 Bridge Parkway
Redwood City CA 94065
Chief Medical Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2024-02-08 3,456 $62.29 36,958 No 4 S Direct
Common Stock Disposition 2024-02-09 3,688 $63.40 33,270 No 4 S Direct
Common Stock Disposition 2024-02-12 2,967 $64.46 30,303 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. Represents a broker-assisted sale to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units.
  2. The price reported reflects the weighted average sales price. These shares were sold in multiple transactions at prices that were not available from the broker at the time of filing. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.